Wave Life Sciences Ltd (WVE) saw an uptrend of 3.61% in the recent trading with $1410000.0 being its most recent. The current price level -59.67% lower than the highest price of $16.74 marked by the stock while trading over the past 52-weeks, whereas it is 33.93% higher than the lowest price of $5.04 the company dropped to over past 52-weeks. The latest news story on WVE appeared in (GlobeNewswire) under the title “Wave Life Sciences Announces Oral Presentation of Preclinical Data Supporting WVE-007’s Mechanism (INHBE) to Reduce Fat, Preserve Muscle, and Induce Healthy Weight Loss at ADA’s Annual Scientific Sessions” on Jun-20-25.
Do analysts rate it as a buy, sell or hold?
Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Currently, the stock has been recommended as Strong Buy by 3 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.23 for the stock.
Wave Life Sciences Ltd Earnings – What Happened With WVE
Coming around sales and income figures on WVE Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.
Wave Life Sciences Ltd – Insider Activity and Holdings
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 154.09 million. WVE does have institutional investors; and they hold 80.71% of the stock.
As on 2024-06-30, RA CAPITAL MANAGEMENT, L.P. was the top most holder in Wave Life Sciences Ltd (NASDAQ:WVE) with an ownership of 18.2 million shares of the company or 14.0527 of the stake worth $90.83 million. The filing also reveals MAVERICK CAPITAL LTD as the second largest holder in the company with a control over 5.9211 of the outstanding shares. Its stake is worth $38.27 million for having 7.67 million shares in hand.
BLACKROCK INC. also came holding a key position in the company during the recent quarter and it now holds 5.2026 of the outstanding shares. With this there are now 262.0 institutions which have possession in WVE’s shares.
Key Metrics forWVE
The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, Wave Life Sciences Ltd has a debt to equity ratio of 0.13.
Technical Analysis of Wave Life Sciences Ltd (NASDAQ:WVE) stock
To comprehend better with the trade moves and investors’ behavior, exploring the short, medium and long term technical indicators along with average volume of a stock is an effective way to make use of. When looking into those indicators for Wave Life Sciences Ltd (WVE), we notice that the stock’s 20-day average volume is at 1,074,115 shares and 50% of short term indicators are suggesting the stock as Sell. Medium term indicators at an average of 50% are spotting the stock at Sell with its 50-day average volume of 1,338,432 shares. And to end, WVE’s 100-day average volume is 1,312,657 shares with 100% of the long-term indicators pointing towards Sell for the stock.
